524768 EMMESSA

Emmessar Biotech & Nutrition Share Price

 

 

Start SIP in EMMESSA

Start SIP

Performance

  • Low
  • ₹27
  • High
  • ₹31
  • 52 Week Low
  • ₹26
  • 52 Week High
  • ₹47
  • Open Price₹29
  • Previous Close₹30
  • Volume1,389

Investment Returns

  • Over 1 Month -5.66%
  • Over 3 Month -18.1%
  • Over 6 Month -9.66%
  • Over 1 Year -35.71%

Smart Investing Starts Here Start SIP with Emmessar Biotech & Nutrition for Steady Growth!

Invest Now

Emmessar Biotech & Nutrition Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 62
  • PEG Ratio
  • -0.8
  • Market Cap Cr
  • 15
  • P/B Ratio
  • 1.8
  • Average True Range
  • 2
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.44
  • RSI
  • 45.2
  • MFI
  • 72.75

Emmessar Biotech & Nutrition Financials

Emmessar Biotech & Nutrition Technicals

EMA & SMA

Current Price
₹29.00
-0.89 (-2.98%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹29.76
  • 50 Day
  • ₹30.36
  • 100 Day
  • ₹30.96
  • 200 Day
  • ₹32.43

Resistance and Support

28.94 Pivot Speed
  • R3 34.71
  • R2 32.78
  • R1 30.87
  • S1 27.03
  • S2 25.10
  • S3 23.19

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Emmessar Biot.& Nut. has an operating revenue of Rs. 0.38 Cr. on a trailing 12-month basis. An annual revenue growth of 3% is not great, Pre-tax margin of 157% is great, ROE of 4% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 33 which is a POOR score indicating inconsistency in earnings, a RS Rating of 25 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 75 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Emmessar Biotech & Nutrition Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-12 Quarterly Results
2025-08-07 Quarterly Results
2025-04-24 Audited Results
2025-02-06 Quarterly Results
2024-11-07 Quarterly Results

Emmessar Biotech & Nutrition F&O

Emmessar Biotech & Nutrition Shareholding Pattern

59.53%
0.05%
0.14%
38.12%
2.16%

About Emmessar Biotech & Nutrition

  • NSE Symbol
  • EMMESSA
  • BSE Symbol
  • 524768
  • Managing Director
  • Mr. Srinivasa Raghavan Mathurakavi Ayyangar
  • ISIN
  • INE634B01016

Similar Stocks to Emmessar Biotech & Nutrition

Emmessar Biotech & Nutrition FAQs

Emmessar Biotech & Nutrition share price is ₹29 As on 25 December, 2025 | 19:52

The Market Cap of Emmessar Biotech & Nutrition is ₹14.5 Cr As on 25 December, 2025 | 19:52

The P/E ratio of Emmessar Biotech & Nutrition is 62 As on 25 December, 2025 | 19:52

The PB ratio of Emmessar Biotech & Nutrition is 1.8 As on 25 December, 2025 | 19:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23